TY  - CHAP
M1  - Book, Section
TI  - Mannosidosis
A1  - Bissonnette, Bruno
A1  - Luginbuehl, Igor
A1  - Engelhardt, Thomas
Y1  - 2019
N1  - 
T2  - Syndromes: Rapid Recognition and Perioperative Implications, 2e
AB  - It  is  a  lysosomal  glycoprotein  storage  disease  characterized  by  mental  retardation,  hearing  loss,  and  recurrent  infections  (upper  or  lower  respiratory  tract,  and  gastrointestinal  tract).  Other  clinical  features  include  coarse  face,  prominent  forehead,  prominent  jaw,  diffuse  cerebral  dysfunction,  severe  ataxia,  deafness,  scoliosis,  rheumatoid  arthritis,  hypotonia,  and  muscle  pain.  Two  types  have  been  described:  α  and  β  mannosidosis.  The  α-Mannosidosis  displays  clinical  heterogeneity,  ranging  from  very  serious  to  very  mild  forms.  The  β-Mannosidosis  causes  a  severe  disorder  that  affects  the  peripheral  and  central  nervous  systems.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/16
UR  - accessanesthesiology.mhmedical.com/content.aspx?aid=1164077684
ER  -